EP2335719
Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.2.2006EP published:
24.6.2015EP application number:
10196139.9
EPO information:
European Patent Register
Max expiry date:
15.2.2026
Title:
Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism
Timeline
Today
16.2.2006EP application
24.6.2015EP Publication
Owner
Name:
The General Hospital CorporationAddress:
55 Fruit Street, 02114, Boston, MA, US
Inventor
Name:
Lin, Herbert YAddress:
Watertown, MA, US
Name:
Babitt, JodieAddress:
Brighton, MA, US
Name:
Chung, Raymond TAddress:
Chestnut Hill, MA, US
Name:
Samad, Tarek, A.Address:
Guilford, CT, US
Name:
Schneyer, Alan, L.Address:
Concord, MA, US
Name:
Woolf, CliffordAddress:
Newton, MA, US
Priority
Number:
653479 PDate:
16.2.2005Country:
US
Classification
Categories:
A61K 38/17, A61K 47/48, A61K 39/395, A61P 3/02, A61P 7/06